Jerome B. Durso's most recent trade in Altimmune Inc was a trade of 12,500 Common Stock, par value $0.0001 done at an average price of $4.1 . Disclosure was reported to the exchange on Dec. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Altimmune Inc | Jerome B. Durso | Director | Purchase of securities on an exchange or from another person at price $ 4.13 per share. | 22 Dec 2025 | 12,500 | 12,500 (0%) | 0% | 4.1 | 51,569 | Common Stock, par value $0.0001 |
| Altimmune Inc | Jerome B. Durso | Director, CEO-elect | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2025 | 1,824,400 | 1,824,400 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | Jerome B. Durso | Director, CEO-elect | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2025 | 633,700 | 633,700 | - | - | Restricted Stock Units | |
| Altimmune Inc | Jerome B. Durso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2025 | 48,800 | 48,800 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | Jerome B. Durso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 69,800 | 69,800 | - | - | Stock Options (option to buy) | |
| Intercept Pharmaceuticals Inc | Jerome B. Durso | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 82,700 | 82,700 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Jerome B. Durso | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 50,400 | 154,640 (0%) | 0% | 0 | Common Stock | |
| Intercept Pharmaceuticals Inc | Jerome B. Durso | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.37 per share. | 31 Dec 2022 | 7,083 | 104,240 (0%) | 0% | 12.4 | 87,617 | Common Stock |
| Intercept Pharmaceuticals Inc | Jerome B. Durso | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 60,900 | 60,900 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Jerome B. Durso | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 35,700 | 111,323 (0%) | 0% | 0 | Common Stock | |
| Intercept Pharmaceuticals Inc | Jerome B. Durso | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.22 per share. | 01 Oct 2021 | 289 | 81,564 (0%) | 0% | 15.2 | 4,399 | Common Stock |
| Intercept Pharmaceuticals Inc | Jerome B. Durso | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.47 per share. | 01 Jul 2021 | 289 | 81,853 (0%) | 0% | 20.5 | 5,916 | Common Stock |
| Intercept Pharmaceuticals Inc | Jerome B. Durso | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.28 per share. | 01 Apr 2021 | 289 | 82,142 (0%) | 0% | 24.3 | 7,017 | Common Stock |
| Intercept Pharmaceuticals Inc | Jerome B. Durso | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.12 per share. | 23 Feb 2021 | 319 | 82,431 (0%) | 0% | 28.1 | 8,970 | Common Stock |
| Intercept Pharmaceuticals Inc | Jerome B. Durso | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 72,000 | 72,000 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Jerome B. Durso | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 46,000 | 82,750 (0%) | 0% | 0 | Common Stock |